Literature DB >> 15350706

Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients.

Joachim Struck1, Chen Tao, Nils G Morgenthaler, Andreas Bergmann.   

Abstract

Adrenomedullin and PAMP are potent vasodilatory peptides derived from a common larger precursor peptide. Elevation of circulating levels of both peptides has been described for diseases involving dysfunction of the cardiovascular system. However, the reliable quantification has been hampered by their short half-life times and - as known for Adrenomedullin -- the existence of a binding protein. Here we report the identification of another peptide derived from the Adrenomedullin precursor, termed proADM 45-92, which is present in large concentrations in plasma of septic shock patients. This peptide is produced in stoichiometric amounts to Adrenomedullin and PAMP, but -- contrary to them -- is apparently non-functional and stable. Thus, proADM 45-92 represents a suitable diagnostic target which could be used to assess the concentrations of Adrenomedullin gene products released into the bloodstream.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350706     DOI: 10.1016/j.peptides.2004.06.019

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  49 in total

1.  Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification.

Authors:  Habib Bouzina; Göran Rådegran
Journal:  Pulm Circ       Date:  2020-06-15       Impact factor: 3.017

Review 2.  Adrenomedullin and pregnancy: perspectives from animal models to humans.

Authors:  Patricia M Lenhart; Kathleen M Caron
Journal:  Trends Endocrinol Metab       Date:  2012-03-16       Impact factor: 12.015

Review 3.  Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?

Authors:  Mihael Potocki; Ronny Ziller; Christian Mueller
Journal:  Curr Heart Fail Rep       Date:  2012-09

4.  Biomarkers for community-acquired pneumonia in the emergency department.

Authors:  Todd A Florin; Lilliam Ambroggio
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 5.  Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Authors:  Deirdre Morley; Antoni Torres; Catia Cillóniz; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

6.  Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.

Authors:  Quynh A Truong; Emily Siegel; Mahir Karakas; James L Januzzi; Fabian Bamberg; Amir A Mahabadi; Selcuk Dasdemir; Thomas J Brady; Andreas Bergmann; Jan Kunde; John T Nagurney; Udo Hoffmann; Wolfgang Koenig
Journal:  Clin Chem       Date:  2010-02-25       Impact factor: 8.327

7.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Performance evaluation of MR-proadrenomedullin and other scoring systems in severe sepsis with pneumonia.

Authors:  Serdar Akpinar; Kazım Rollas; Ali Alagöz; Fatih Seğmen; Tuğrul Sipit
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

9.  MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.

Authors:  Lars Heining; Christian Giesa; Santiago Ewig
Journal:  Lung       Date:  2016-01-09       Impact factor: 2.584

10.  Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertension.

Authors:  Malik A Al-Omari; Mahyar Khaleghi; Thomas H Mosley; Stephen T Turner; Nils G Morgenthaler; Joachim Struck; Andreas Bergmann; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2009-05-07       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.